Measurement of microalbuminuria using protein chip electrophoresis

American Journal of Clinical Pathology

Volumn 129, Issue 3, 2008, Pages 432-438

  Pandey, Suchitra ^a,b   Lu, Chuanyi M ^c,d   Herold, David A ^a,b,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Chip; Electrophoresis; Immunounreactive albumin; Microalbuminuria; Microfluidics; Protein analysis

Indexed keywords

ACCURACY; ARTICLE; DIABETES MELLITUS; FLUORESCENCE; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREACTIVITY; MICROALBUMINURIA; MICROFLUIDICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SENSITIVITY ANALYSIS; URINALYSIS; ALBUMINURIA; HUMAN; METHODOLOGY; MICROCHIP ELECTROPHORESIS; SENSITIVITY AND SPECIFICITY;

ALBUMINURIA; ELECTROPHORESIS, MICROCHIP; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 41649084176     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/4JU0XQH62D3YLTGK     Document Type: Article

References (25)

1. American Diabetes Association. All About Diabetes. Available at http://www.diabetes.org/about-diabetes.jsp. Accessed December 2006.
2. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Chapter 1: The Public Health Burden of Diabetes Mellitus in the United States: End-Stage Renal Disease. In: Data & Trends: Diabetes Surveillance System: 1999 Surveillance Report. Available at http://www.cdc.gov/diabetes/statistics/ surv199/chap1/renal.htm. Accessed December 2006.
3. American Diabetes Association. Standards of medical care in diabetes [published correction appears in Diabetes Care. 2005;28:990]. Diabetes Care. 2005;28(suppl):S4-S36.
4. Deferrari G, Repetto M, Calvi C, et al. Diabetic nephropathy: from micro- to macroalbuminuria. Nephrol Dial Transplant. 1998;13(suppl 8):11-15.
5. Jerums G, MacIsaac RJ. Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol. 2002;1:163-173.
6. Busby DE, Atkins RC. The detection and measurement of microalbuminuria: a challenge for clinical chemistry. MLO Med Lab Obs. 2005;37:8-16.
7. Babazono T, Takahashi C, Iwamoto Y. Definition of microalbuminuria in first-morning and random spot urine in diabetic patients [letter]. Diabetes Care. 2004;27:1838-1839.
8. Erdmann E. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Int J Cardiol. 2006;107:147-153.
9. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med. 2003;254:45-66.
10. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17:2100-2105.
11. Mogensen CE. Preventing end-stage renal disease. Diabet Med. 1998;15(suppl 4):S51-S56.
12. Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis. 2006;47:927-946.
13. Yuyun MF, Adler AI, Wareham NJ. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens. 2005;14:271-276.
14. Tiu SC, Lee SS, Cheng MW. Comparison of six commercially available techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care. 1993;16:616-620.
15. Grieve KA, Eppel GA, Reeve S, et al. Immunounreactive albumin excretion increases in streptozotocin diabetic rats. Am J Kidney Dis. 2001;38:144-152.
16. Brinkman JW, Bakker SJL, Gansevoort RT, et al. Which method for quantifying urinary albumin excretion gives what outcome? a comparison of immunonephelometry and with HPLC. Kidney Int Suppl. 2004;66:S69-S75.
17. Comper WD, Osicka TM, Jerums G. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients. Am J Kidney Dis. 2003;41:336-342.
18. Owen WE, Roberts WL. Performance characteristics of an HPLC assay for urinary albumin. Am J Clin Pathol. 2005;124:219-225.
19. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem. 2004;50:2286-2291.
20. Sviridov D, Meilinger B, Drake SK, et al. Coelution of other proteins with albumin during size exclusion HPLC: implications for analysis of urinary albumin. Clin Chem. 2006;52:389-397.
21. Bousse L, Mouradian S, Minala A, et al. Protein sizing on a microchip. Anal Chem. 2001;73:1207-1212.
22. Kuschel M, Neuman T, Barthmaier P, et al. Use of lab-on-a-chip technology for protein sizing and quantitation. J Biomol Tech. 2002;13:172-178.
23. Chan OTM, Herold DA. Chip electrophoresis as a method for quantifying total microalbuminuria. Clin Chem. 2006;52:2141-2146.
24. Comper WD, Osicka TM, Clark M, et al. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int. 2004;65:1850-1855.
25. Peters T. New form of urinary albumin in early diabetes [editorial]. Clin Chem. 2004;50:2238-2239.